cGAS-STING and neurodegenerative diseases: A molecular crosstalk and therapeutic perspective
International Immunopharmacology · 2025-06 · 159 · 114902
DOI: 10.1016/j.intimp.2025.114902 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2025-06. Verfasst von Rishika Dhapola und 6 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Pharmacology and Neuroscience Laboratory, Department of Pharmacology, School of Health Sciences, Central University of Punjab, Ghudda, Bathi…. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Neurodegenerative Diseases, Membrane Proteins. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: Servier, Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS) and Frontotemporal Dementia (FTD) share key pathological features, including neuroinflammation, oxidative stress, mitochondrial dysfunction, autophagic dysfunction, and DNA damage. By identifying cytosolic DNA and triggering the type I interferon response, the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway regulates neuroinflammation. Dysregulated cGAS-STING signaling has been linked to neuroinflammation and neuronal degeneration across multiple neurodegenerative conditions. In many neurodegenerative disorders, neuroinflammation is mediated by the cGAS-STING pathway. Mitochondrial malfunction and impaired autophagy cause cytosolic DNA buildup in Huntington's, Parkinson's, and Alzheimer's diseases, which activates cGAS-STING and drives chronic inflammation. This pathway is triggered by TDP-43 pathology and nucleic acid dysregulation in ALS and FTD, which leads to neuronal destruction. Both central demyelination and peripheral immunological responses are linked to cGAS-STING activation in multiple sclerosis. Various inhibitors, such as RU.521, H-151, and naturally occurring compounds like metformin, potentially attenuate cGAS-STING-mediated neuroinflammation and associated pathologies. H-151 significantly decreased the expression of pro-inflammatory markers in murine macrophage J774 cells activated with cGAMP: TNF-α by 68 %, IFN-β by 84 %, and CXCL10 by 96 %. cGAS-STING inhibitors target neuroinflammation, offering a disease-modifying approach unlike current symptomatic treatments. However, challenges like blood-brain barrier penetration, off-target effects, and immune suppression hinder clinical translation, necessitating optimized drug delivery and immune modulation. With a focus on its potential for future clinical applications, this review explores the role of the cGAS-STING pathway in neurodegeneration and new treatment approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Advanced Pharmacology and Neuroscience Laboratory, Department of Pharmacology, School of Health Sciences, Central University of Punjab, Ghudda, Bathinda 151401, Punjab, India.
- Human Cytogenetics and Stem Cell Laboratory, Department of Zoology, School of Basic Sciences, Central University of Punjab, 151401 Bathinda, Punjab, India.
- Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.
- Advanced Pharmacology and Neuroscience Laboratory, Department of Pharmacology, School of Health Sciences, Central University of Punjab, Ghudda, Bathinda 151401, Punjab, India. Electronic address: harikrishnareddy0011@gm…
Förderung
- Servier
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Dhapola, R., Paidlewar, M., Kumari, S., Sharma, P., Vellingiri, B., Medhi, B., & HariKrishnaReddy, D. (2025). cGAS-STING and neurodegenerative diseases: A molecular crosstalk and therapeutic perspective. International Immunopharmacology, 159, 114902. https://doi.org/10.1016/j.intimp.2025.114902
Vancouver
Dhapola R, Paidlewar M, Kumari S, Sharma P, Vellingiri B, Medhi B, et al. cGAS-STING and neurodegenerative diseases: A molecular crosstalk and therapeutic perspective. International Immunopharmacology. 2025;159:114902. doi:10.1016/j.intimp.2025.114902
BibTeX
@article{Dhapola2025,
author = {Dhapola, Rishika and Paidlewar, Mohit and Kumari, Sneha and Sharma, Prajjwal and Vellingiri, Balachandar and Medhi, Bikash and HariKrishnaReddy, Dibbanti},
title = {cGAS-STING and neurodegenerative diseases: A molecular crosstalk and therapeutic perspective},
journal = {International Immunopharmacology},
year = {2025},
volume = {159},
pages = {114902},
doi = {10.1016/j.intimp.2025.114902}
}
EUVIMED